# Biomarkers to Predict Time to Plasma HIV RNA Rebound

> **NCT03001128** · — · COMPLETED · sponsor: **Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections** · enrollment: 61 (actual)

## Conditions studied

- HIV-1 Infection

## Interventions

- **DRUG:** Antiretroviral treatment pause

## Key facts

- **NCT ID:** NCT03001128
- **Lead sponsor:** Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-23
- **Primary completion:** 2021-01-29
- **Final completion:** 2021-01-29
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2024-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03001128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03001128, "Biomarkers to Predict Time to Plasma HIV RNA Rebound". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03001128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*